LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 54 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | -66.7% | 60 | -83.3% | 0.00% | -100.0% |
| Q4 2016 | $6,000 | +100.0% | 360 | +200.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | +50.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -33.3% | 120 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $3,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $3,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $3,000 | -72.7% | 120 | -80.6% | 0.00% | -66.7% |
| Q1 2015 | $11,000 | +450.0% | 620 | +416.7% | 0.00% | – |
| Q4 2014 | $2,000 | -50.0% | 120 | -68.4% | 0.00% | -100.0% |
| Q3 2014 | $4,000 | -42.9% | 380 | -49.5% | 0.00% | 0.0% |
| Q2 2014 | $7,000 | -50.0% | 753 | -43.8% | 0.00% | -66.7% |
| Q1 2014 | $14,000 | – | 1,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,872,130 | $77,548,000 | 30.77% |
| RTW INVESTMENTS, LP | 1,084,416 | $29,279,000 | 9.67% |
| Avoro Capital Advisors LLC | 784,199 | $21,173,000 | 7.29% |
| Broadfin Capital, LLC | 1,165,373 | $31,465,000 | 1.94% |
| P.A.W. CAPITAL CORP | 50,400 | $1,361,000 | 1.54% |
| Belmont Global Advisors, Inc. | 37,522 | $1,013,000 | 1.31% |
| Perceptive Advisors | 649,515 | $17,537,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 82,920 | $2,239,000 | 1.07% |
| Iguana Healthcare Management, LLC | 110,000 | $2,970,000 | 0.98% |
| Virtus ETF Advisers LLC | 10,250 | $277,000 | 0.76% |